EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (15 hours ago)
OpenTox Euro 2018 in Athens, Greece - We are pleased to announce that the complete OpenTox Euro 2018 Conference Pro… https://t.co/uIZJVAlkh3
Douglas Connect (4 days ago)
RT @LucianFarcal: Presenting the concept and latest achievements on protocols and data management related to phys-chem characterisation of…
Douglas Connect (5 days ago)
Exploring AI and Machine Learning Approaches to Precision Medicine and Healthcare - Join us for discussion in Phila… https://t.co/2j9ijVonna
Douglas Connect (5 days ago)
Making Evidence-based Decisions in a World of Fake News - how can we better the situation? Scientific research is n… https://t.co/8fqDmryiLW
Douglas Connect (5 days ago)
OpenTox Euro 2018 will commence next month in Athens! The chosen theme for this year's conference will be "Bridging… https://t.co/lPZu5iYV2X

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com